DENTSPLY SIRONA Inc. (XRAY) shares saw a recent bid of $63.52 and 1.41M shares have exchanged hands in the recent trading session, yielding a 0.59% gain over the past week. The stock price increased 1.44% or $-0.9 versus $62.62 at the end of the prior session. This change led market cap to move at $14.64B, putting the price -3.51% below the 52-week high and 15.49% above the 52-week low. The company’s stock has a normal trading capacity of 1.26M shares while the relative volume is 1.12.
By historical standards, DENTSPLY SIRONA Inc. remains a cheap stock. The company’s current price-earnings ratio amounts to 40.46 times earnings, above the average P/E ratio of 31.97 times earnings. For now, DENTSPLY SIRONA Inc. is the toast of Wall Street as its ABR stands at 2.10 with 6 out of 15 analysts rating the stock a buy. Over the short term, some market observers may have noticed that DENTSPLY SIRONA Inc. has a 2.65% short float with 15 days to cover. It becomes significant when you consider how many shares are shorted versus the average daily volume, means how many days to cover those short shares at that volume. DENTSPLY SIRONA Inc. has far performed well this year, with the share price up 10.03% since January. Over the past 2 quarters, the stock is up 5.10%, compared with a fall of nearly -1.52% for 3 months and about 0.79% for the past 30 days.
Last time, the company failed Wall Street by reporting EPS of $0.49, smashing the consensus of $0.50 per share. Revenue for the quarter also did not kill consensus, coming in at $902M, compared to the consensus of 916.55M. Nonetheless, from here on out, earnings per share forecasts for the current quarter are $0.65. The company is expected to report EPS as high as $0.70 and as low as $0.59 per share. Similarly, full-year EPS forecasts have ranged between $2.80 and $2.86. The mean EPS estimate is $2.84. On the other side, sales forecasts for the current quarter are $998.83M. The stock is expected to report revenue as high as $1.02B and as low as $967M per share. Similarly, full-year sales forecasts have ranged between $3.94B and $4.05B. The mean revenue estimate is $4.01B.
Over the last 5 years, DENTSPLY SIRONA Inc. has averaged a 2.60% YoY EPS growth rate and a 8.10% revenue growth rate. Analysts are expecting EPS growth rates to be at 10.10% this quarter and EPS estimate for next year reflect 12.62% growth rate.
Sell-side analysts also have something to say about this company. Goldman had a markedly different take on 23/05/2017, proposing that DENTSPLY SIRONA Inc. is now considered Sell versus prior Neutral rating. Barrington Research had a markedly different take on 21/02/2017, proposing that DENTSPLY SIRONA Inc. is now considered Mkt Perform versus prior Outperform rating. Stifel raised its rating on DENTSPLY SIRONA Inc. to Buy on 14/02/2017 in a reversal from its prior Hold rating. Barrington Research raised its rating on DENTSPLY SIRONA Inc. to Outperform on 05/12/2016 in a reversal from its prior Mkt Perform rating.